Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains.

Antimicrobial Agents and Chemotherapy
Guido MemmiAmbrose Cheung

Abstract

Recent cases of infections caused by community-acquired methicillin-resistant Staphylococcus aureus (MRSA) (CA-MRSA) strains in healthy individuals have raised concerns worldwide. CA-MRSA strains differ from hospital-acquired MRSAs by virtue of their genomic background and increased virulence in animal models. Here, we show that in two common CA-MRSA isolates, USA300 and MW2 (USA400), a loss of penicillin binding protein 4 (PBP4) is sufficient to cause a 16-fold reduction in oxacillin and nafcillin resistance, thus demonstrating that mecA, encoding PBP2A, is not the sole determinant of methicillin resistance in CA-MRSA. The loss of PBP4 was also found to severely affect the transcription of PBP2 in cells after challenge with oxacillin, thus leading to a significant decrease in peptidoglycan cross-linking. Autolysis, which is commonly associated with the killing mechanism of penicillin and beta-lactams, does not play a role in the reduced resistance phenotype associated with the loss of PBP4. We also showed that cefoxitin, a semisynthetic beta-lactam that binds irreversibly to PBP4, is synergistic with oxacillin in killing CA-MRSA strains, including clinical CA-MRSA isolates. Thus, PBP4 represents a major target for drug redisco...Continue Reading

References

Dec 1, 1978·Antimicrobial Agents and Chemotherapy·S R Nair, C E Cherubin
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·N H GeorgopapadakouD P Bonner
Jul 1, 1980·Antimicrobial Agents and Chemotherapy·N H Georgopapadakou, F Y Liu
Nov 1, 1995·Antimicrobial Agents and Chemotherapy·U U Henze, B Berger-Bächi
Jul 1, 1996·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·U U HenzeB Berger-Bächi
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G L Archer
Jun 26, 1999·The Journal of Biological Chemistry·K SieradzkiA Tomasz
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G LinaJ Etienne
Aug 23, 2001·Proceedings of the National Academy of Sciences of the United States of America·M G PinhoA Tomasz
Sep 18, 2001·JAMA : the Journal of the American Medical Association·A V GroomJ E Cheek
Apr 16, 2002·Molecular Microbiology·R Allyn ForsythJudith W Zyskind
Jun 5, 2002·Lancet·Tadashi BabaKeiichi Hiramatsu
Oct 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maria E RuizCarmelita U Tuazon
Jun 7, 2003·Molecular Microbiology·S S IngavaleA L Cheung
Mar 6, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yuki KatayamaHenry F Chambers
May 26, 2004·FEMS Microbiology Letters·Goretti Mallorquí-FernándezF Xavier Gomis-Rüth
Nov 6, 2004·Applied and Environmental Microbiology·Maryvonne ArnaudMichel Débarbouillé
Nov 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin P HowdenM Lindsay Grayson
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John S FrancisJohn G Bartlett
Feb 4, 2005·The New England Journal of Medicine·Sophia V KazakovaDaniel B Jernigan
Apr 9, 2005·The New England Journal of Medicine·Loren G MillerBrad Spellberg
Jun 21, 2005·Emerging Infectious Diseases·Gregory J MoranDavid A Talan
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jovanka M VoyichFrank R DeLeo
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ulrich SeyboldHenry M Blumberg
Feb 4, 2006·Journal of Clinical Microbiology·Daniel J Skiest
Mar 11, 2006·International Journal of Antimicrobial Agents·Ana C GalesAfonso L Barth
Mar 15, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·David HirschwerkSusan Condon
Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Oct 24, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Fuat H SanerChristoph E Broelsch

❮ Previous
Next ❯

Citations

Dec 14, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M GazinUNKNOWN MOSAR WP2 Study Team
Jan 24, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R BanerjeeR Patel
Mar 28, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N FaragM El-Azizi
Nov 26, 2013·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jessica K OrtwineMichael J Rybak
Oct 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Magda L AtilanoSérgio R Filipe
Mar 24, 2012·Science Translational Medicine·Christopher M TanTerry Roemer
May 9, 2012·Antimicrobial Agents and Chemotherapy·Aneela Qamar, Dasantila Golemi-Kotra
Sep 29, 2011·Antimicrobial Agents and Chemotherapy·Nadine GöhringAndreas Peschel
Oct 31, 2013·The Journal of Antibiotics·Edward W C Sewell, Eric D Brown
May 7, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Teresa A FigueiredoRita G Sobral
Oct 8, 2014·Journal of the American Chemical Society·Yuan QiaoSuzanne Walker
Jul 25, 2015·Angewandte Chemie·Samir GautamDavid A Spiegel
Aug 19, 2015·Nature Communications·João M MonteiroMariana G Pinho
Jun 3, 2015·Journal of the American Chemical Society·Samir GautamDavid A Spiegel
Jul 31, 2013·Current Opinion in Microbiology·Terry RoemerMariana G Pinho
Nov 10, 2015·Indian Journal of Pathology & Microbiology·Oyebode Armstrong Terry AlliJohn B Daniel
Dec 20, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sabrina Di GregorioMarta Mollerach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.